These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8930956)

  • 1. Possible implication of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano body formation.
    Mitake S; Katada E; Otsuka Y; Matsukawa N; Iwase T; Tsugu T; Fujimori O; Ojika K
    Neuropathol Appl Neurobiol; 1996 Oct; 22(5):440-5. PubMed ID: 8930956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano bodies.
    Mitake S; Ojika K; Katada E; Otsuka Y; Matsukawa N; Fujimori O
    Neuropathol Appl Neurobiol; 1995 Feb; 21(1):35-40. PubMed ID: 7770119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hirano bodies and Alzheimer's disease.
    Mitake S; Ojika K; Hirano A
    Kaohsiung J Med Sci; 1997 Jan; 13(1):10-8. PubMed ID: 9130818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease.
    Münch G; Cunningham AM; Riederer P; Braak E
    Brain Res; 1998 Jun; 796(1-2):307-10. PubMed ID: 9689484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The involvement of hippocampal cholinergic neurostimulating peptide and its precursor in Alzheimer pathogenesis].
    Matsukawa N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2014 Jun; 34(3):93-100. PubMed ID: 25076779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-localization of hippocampal cholinergic neurostimulating peptide precursor with collapsin response mediator protein-2 at presynaptic terminals in hippocampus.
    Kato D; Mitake S; Mizuno M; Kanamori T; Suzuki T; Ojika K; Matsukawa N
    Neurosci Lett; 2012 May; 517(2):92-7. PubMed ID: 22542739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hirano bodies contain tau protein.
    Galloway PG; Perry G; Kosik KS; Gambetti P
    Brain Res; 1987 Feb; 403(2):337-40. PubMed ID: 3103867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of FAC1 protein in Hirano bodies.
    Jordan-Sciutto K; Dragich J; Walcott D; Bowser R
    Neuropathol Appl Neurobiol; 1998 Oct; 24(5):359-66. PubMed ID: 9821166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme q induces tau aggregation, tau filaments, and Hirano bodies.
    Santa-Mara I; Santpere G; MacDonald MJ; Gomez de Barreda E; Hernandez F; Moreno FJ; Ferrer I; Avila J
    J Neuropathol Exp Neurol; 2008 May; 67(5):428-34. PubMed ID: 18431254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus.
    Schmidt ML; Lee VM; Trojanowski JQ
    Lab Invest; 1989 Apr; 60(4):513-22. PubMed ID: 2468822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Enhancement Effect of Hippocampal Cholinergic Neurostimulating Peptide on Cholinergic Activity in the Hippocampus.
    Madokoro Y; Kato D; Tsuda Y; Arakawa I; Suzuki K; Sato T; Mizuno M; Uchida Y; Ojika K; Matsukawa N
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pick body-like inclusions in the dentate fascia of the hippocampus in Alzheimer's disease.
    Dickson DW; Yen SH; Horoupian DS
    Acta Neuropathol; 1986; 71(1-2):38-45. PubMed ID: 3022536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Cholinergic Activity in the Hippocampus of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein Knockout Mice.
    Madokoro Y; Yoshino Y; Kato D; Sato T; Mizuno M; Kanamori T; Shimazawa M; Hida H; Hara H; Yoshida M; Borlongan CV; Ojika K; Matsukawa N
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques.
    Lee SC; Zhao ML; Hirano A; Dickson DW
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1163-9. PubMed ID: 10560659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-cleaved actin (fractin) immunolabelling of Hirano bodies.
    Rossiter JP; Anderson LL; Yang F; Cole GM
    Neuropathol Appl Neurobiol; 2000 Aug; 26(4):342-6. PubMed ID: 10931367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease.
    Maki M; Matsukawa N; Yuasa H; Otsuka Y; Yamamoto T; Akatsu H; Okamoto T; Ueda R; Ojika K
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):176-85. PubMed ID: 11853019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
    Amador-Ortiz C; Lin WL; Ahmed Z; Personett D; Davies P; Duara R; Graff-Radford NR; Hutton ML; Dickson DW
    Ann Neurol; 2007 May; 61(5):435-45. PubMed ID: 17469117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.
    Arai Y; Yamazaki M; Mori O; Muramatsu H; Asano G; Katayama Y
    Brain Res; 2001 Jan; 888(2):287-296. PubMed ID: 11150486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed neural lineage differentiation of adult hippocampal progenitor cells via modulation of hippocampal cholinergic neurostimulating peptide precursor expression.
    Sagisaka T; Matsukawa N; Toyoda T; Uematsu N; Kanamori T; Wake H; Borlongan CV; Ojika K
    Brain Res; 2010 Apr; 1327():107-17. PubMed ID: 20206149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytosolic inclusion bodies that consist of splice variants that lack exon 5 of the presenilin-2 gene differ obviously from Hirano bodies observed in the brain from sporadic cases of Alzheimer's disease patients.
    Manabe T; Katayama T; Sato N; Kudo T; Matsuzaki S; Imaizumi K; Tohyama M
    Neurosci Lett; 2002 Aug; 328(2):198-200. PubMed ID: 12133587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.